{"effective_time":"20240509","id":"180c2238-f5f5-e191-e063-6394a90a9bca","indications_and_usage":["INDICATIONS AND USAGE XCOPRI is indicated for the treatment of partial-onset seizures in adult patients."],"openfda":{},"package_label_principal_display_panel":["250 mg Maintenance","250 mg Maintenance","350 mg Maintenance","350 mg Maintenance","50 Titration","100 mg Titration","150 mg Titration","200 mg Titration","12.5 mg Titration","25 mg Titration","25 mg Titration"],"set_id":"0f2c0e91-f75a-5b29-e063-6294a90abf1a","spl_product_data_elements":["XCOPRI TITRATION PACK 50 mg, 100 mg cenobamate CENOBAMATE CENOBAMATE SK;100 XCOPRI TITRATION PACK 12.5 mg, 25 mg cenobamate CENOBAMATE CENOBAMATE SK;25 XCOPRI TITRATION PACK 12.5 mg, 25 mg cenobamate CENOBAMATE CENOBAMATE SK;12 XCOPRI TITRATION PACK 150 mg, 200 mg cenobamate CENOBAMATE CENOBAMATE SK;150 (light orange) XCOPRI TITRATION PACK 150 mg, 200 mg cenobamate CENOBAMATE CENOBAMATE Modified Oval SK;200 (light orange) XCOPRI MAINTENANCE PACK 100 mg, 150 mg cenobamate CENOBAMATE CENOBAMATE SK;100 XCOPRI MAINTENANCE PACK 100 mg, 150 mg cenobamate CENOBAMATE CENOBAMATE SK;150 (light orange) XCOPRI MAINTENANCE PACK 150 mg, 200 mg cenobamate CENOBAMATE CENOBAMATE modified oval SK;200 (light orange) XCOPRI MAINTENANCE PACK 150 mg, 200 mg cenobamate CENOBAMATE CENOBAMATE SK;150 (light orange) XCOPRI TITRATION PACK 50 mg, 100 mg cenobamate CENOBAMATE CENOBAMATE SK;50"],"version":"2"}